Proteomics Analysis for Verification of Rheumatoid Arthritis Biomarker Candidates Using Multiple Reaction Monitoring
Authors:
- 9 October 2018
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 13 (3) , e1800011
Abstract
Purpose: Rheumatoid arthritis (RA) is an autoimmune disease in which autoantibodies attack the synovial membrane, causing joint inflammation. Blood tests would offer a powerful, minimally invasive method for early diagnosis of RA. However, no reliable biomarkers for RA are presently available. The aim is to develop biomarkers for RA by multiple reaction monitoring (MRM)‐based quantification of candidate biomarkers.Experimental design: Proteomics approaches are commonly used to identify and verify disease biomarkers. For discovery of biomarkers for RA, SWATH acquisition is performed and selected candidate biomarkers are validated by MRM. Target serum proteins are compared between patients with RA and healthy controls divided into three groups based on rheumatoid factor level.Results: A total of 45 differentially expressed proteins are identified, as determined by SWATH acquisition. Of these, 13 proteins are selected as novel candidate biomarkers. A total of five proteins (transthyretin, gelsolin, angiotensinogen, lipopolysaccharide‐binding protein, and protein S100‐A9) are shown to have the potential to distinguish patients with RA from healthy controls.Conclusions and clinical relevance: These five proteins may improve the efficiency of diagnosis of RA. MRM can be used to easily diagnose RA by detecting five proteins simultaneously in a single sample with high sensitivity.Keywords
Funding Information
- National Research Foundation of Korea (2016M3A9B694241)
This publication has 29 references indexed in Scilit:
- The Pathogenesis of Rheumatoid ArthritisNew England Journal of Medicine, 2011
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questionsNature Reviews Rheumatology, 2011
- Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope DilutionMolecular & Cellular Proteomics, 2009
- Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokinesAnnals of the Rheumatic Diseases, 2007
- Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitisArthritis & Rheumatism, 2007
- Oxygen and reactive oxygen species in cartilage degradation: friends or foes?Osteoarthritis and Cartilage, 2005
- Control of dendritic cell differentiation by angiotensin IIThe FASEB Journal, 2003
- Angiotensin II Activates the Proinflammatory Transcription Factor Nuclear Factor-κB in Human MonocytesBiochemical and Biophysical Research Communications, 1999
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Retinol-binding protein: the transport protein for vitamin A in human plasmaJournal of Clinical Investigation, 1968